Everest Medicines Limited announced that Dr. Kerry Blanchard has resigned as Chief Executive Officer, effective immediately. He will remain as an advisor to Everest for the six months following his resignation. The Board has appointed Mr. Ian Woo, President and CFO of Everest Medicines, to assume the interim duties and responsibilities of the CEO.

The Board believes that having acted as President and CFO since 2018, Mr. Woo will successfully steer the Company decisively through this current period of transition and transformation.